Stifel Nicolaus Restarts Ocera Therapeutics (OCRX) at Buy

December 30, 2013 7:29 AM EST Send to a Friend
Get Alerts OCRX Hot Sheet
Price: $5.40 +3.05%

Rating Summary:
    4 Buy, 0 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 14 | Down: 25 | New: 20
Trade OCRX Now!
Join SI Premium – FREE
Stifel Nicolaus reinstates Ocera Therapeutics (Nasdaq: OCRX) at Buy and price target of $19.

For an analyst ratings summary and ratings history on Ocera Therapeutics click here. For more ratings news on Ocera Therapeutics click here.

Shares of Ocera Therapeutics closed at $11.70 last Fridy.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Analyst PT Change, New Coverage

Related Entities

Stifel Nicolaus

Add Your Comment